Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Himani Aggarwal"'
Autor:
Marina C. Garassino, MD, Sabine Oskar, PhD, MPH, Ashwini Arunachalam, MPH, BDS, Ke Zu, PhD, ScD, MPH, Yu-Han Kao, PhD, Cai Chen, PhD, Weilin Meng, MEng, M. Catherine Pietanza, MD, Bin Zhao, MD, Himani Aggarwal, MPhil, PhD
Publikováno v:
JTO Clinical and Research Reports, Vol 4, Iss 10, Pp 100568- (2023)
Introduction: Data on utilization and clinical outcomes of programmed cell death protein or programmed death-ligand 1 (PD-[L]1) inhibitors in NSCLC with uncommon oncogenic alterations is limited. Methods: This retrospective study used a deidentified
Externí odkaz:
https://doaj.org/article/1969648679be4785880ac7e95d565f5e
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 2 (2023)
Aim: This real-world study aims to compare overall survival (OS) associated with biweekly (Q2W) versus weekly (Q1W) cetuximab dosing regimens for metastatic colorectal cancer (mCRC) treatment in the US. Methods: Adult patients with KRAS wild-type m
Externí odkaz:
https://doaj.org/article/3d3a14ada5a24baf94879848d762bf5d
Autor:
Himani Aggarwal, Kerigo Ndirangu, Katherine B Winfree, Catherine Elizabeth Muehlenbein, Emily Zhu, Vanita Tongbram, Howard Thom
Publikováno v:
Journal of Comparative Effectiveness Research, Vol 12, Iss 2 (2023)
Introduction: In the absence of head-to-head trials comparing immunotherapies for advanced nonsquamous non-small-cell lung cancer (NsqNSCLC), a network meta-analysis (NMA) was conducted to compare the relative efficacy of these treatments. Material
Externí odkaz:
https://doaj.org/article/3d55849932a942438273d8c2ed031e88
Publikováno v:
Health and Quality of Life Outcomes, Vol 18, Iss 1, Pp 1-14 (2020)
Abstract Background To compare quality of life of patients treated with cetuximab with or without radiation therapy (±RT) vs. cisplatin±RT for locoregionally advanced squamous cell carcinoma of the head and neck (SCCHN) in the real-world setting. M
Externí odkaz:
https://doaj.org/article/4bbdccb926eb4645b3e424e7271cf9c2
Publikováno v:
Journal of the National Comprehensive Cancer Network. 21:HSR23-107
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f9096b45256812e7fe5325ac619113
https://doi.org/10.6004/jnccn.2022.7186
https://doi.org/10.6004/jnccn.2022.7186
Autor:
Himani Aggarwal, KayOnda Bayo, Yimei Han, Catherine Elizabeth Muehlenbein, Yajun Emily Zhu, Jong Seok Kim
Publikováno v:
Immunotherapy. 15:267-281
Aim: To evaluate treatment patterns and overall survival (OS) in real world metastatic non-squamous non-small-cell lung cancer (NSQ-NSCLC) patients that received pembrolizumab plus pemetrexed-platinum (pembro+pem+plat) aligned with KEYNOTE-189. Mater
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1f17ce5122a081836079b2e2b9256c2
https://doi.org/10.2217/imt-2022-0166
https://doi.org/10.2217/imt-2022-0166
Publikováno v:
PARIPEX INDIAN JOURNAL OF RESEARCH. :3-6
Introduction: TORCH stands for Toxoplasma gondii, Rubella virus, Cytomegalo virus (CMV) and Herpes simplex virus2 (HSV-2). These infections are transmitted to the foetus through transplacental route at any time during gestation or sometimes at the ti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dde5e2240c4f64f23e7bb263e2338618
https://doi.org/10.36106/paripex/2900290
https://doi.org/10.36106/paripex/2900290
Autor:
Lan Ni, Azhar Zaman Khan, Amanda Long, Ling Gao, Nikki Toms, Elena Gonzalez‐Gugel, Susan Holsmer‐Brand, Yong Lin, Paolo Abada, Sandra Dickin, Declan O'Dea, Ran Wei, Min‐Hua Jen, Himani Aggarwal
Publikováno v:
Clinical Pharmacology & Therapeutics.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5e2210d75348caa1559f32a9286fc76d
https://doi.org/10.1002/cpt.2919
https://doi.org/10.1002/cpt.2919
Autor:
Umang Swami, Himani Aggarwal, Mo Zhou, Shan Jiang, Jeri Kim, Weiyan Li, François Laliberté, Bruno Emond, Neeraj Agarwal
Publikováno v:
Clinical Genitourinary Cancer.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c2e6619657d5faadda3ba175f7b6846b
https://doi.org/10.1016/j.clgc.2023.04.014
https://doi.org/10.1016/j.clgc.2023.04.014
Autor:
Anna Hung, Danielle Candelieri, Yanhong Li, Patrick Alba, Brian Robison, Fatai Agiri, Cristina Perez, Kyung-Min Lee, Kara N. Maxwell, Weiyan Li, Himani Aggarwal, Kathryn Pridgen, Shelby D. Reed, Scott DuVall, Yu-Ning Wong, Julie A. Lynch
Publikováno v:
Seminars in Oncology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2e13c08cda702f97cc6da81b4f7018ef
https://doi.org/10.1053/j.seminoncol.2023.03.001
https://doi.org/10.1053/j.seminoncol.2023.03.001